Cat:GMP-IVD-P005-Tg001
Awaiting product image
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
SKU GMP-IVD-P005-Tg001 Categories , Tag

For more than 100mg, click here for inquiry. >>

Product Details

Genemedi produces core diagnostic ingredients for test of Infectious disease (AIDS) and related syndrome. GeneMedi offers paired diagnostics grade immunodeficiency virus 1/2 (HIV p24 antigen) antibodies (monoclonal antibody, mab) and antigens for Infectious disease (AIDS) rapid test kit of immunodeficiency virus 1/2 (HIV p24 antigen) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Infectious disease (AIDS ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.The immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes the acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells.

Product Description

Cat No. of Pruducts

GMP-IVD-P005-Tg001-Ag01:Recombinant immunodeficiency virus 1/2 (HIV1/2) HIV p24 antigen Protein

Product Name

Recombinant immunodeficiency virus 1/2 (HIV1/2) HIV p24 antigen Protein

Target

immunodeficiency virus 1/2

Alias of Target/Biomarker

#N/A

Expression platform

E.coli

Isotypes

Recombinant Antigen

Bioactivity validation

immunodeficiency virus 1/2 (HIV p24 antigen) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HIV p24 antigen level test of Infectious disease (AIDS) and related syndrome evaluation

Tag

His

Products description

Recombinant immunodeficiency virus 1/2 (HIV1/2) HIV p24 antigen Protein was expressed in E.coli -based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.

Reconized/Reactive Species

immunodeficiency virus 1/2 (HIV1/2)

Purity

Purity: ≥95% (SDS-PAGE)

Application

Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.

Formulation

Supplied as a 0.2 μM filtered solution of PBS,PH7.4.

Storage

Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Genemeidi Omicron Variant Products
test
Previous slide
Next slide

Cat No. of Pruducts

GMP-IVD-P005-Tg001-Ab01,GMP-IVD-P005-Tg001-Ab02:Anti-immunodeficiency virus 1/2 (HIV1/2) HIV p24 antigen mouse monoclonal antibody (mAb)

Product Name

Anti-immunodeficiency virus 1/2 (HIV1/2) HIV p24 antigen mouse monoclonal antibody (mAb)

Target

human immunodeficiency virus 1/2 (HIV1/2)

Alias of Target/Biomarker

#N/A

Expression platform

Hybridoma

Isotypes

Mouse IgG

Bioactivity validation

immunodeficiency virus 1/2 (HIV1/2) human immunodeficiency virus 1/2 (HIV p24 antigen) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other human immunodeficiency virus 1/2 (HIV p24 antigen) antibodies in HIV p24 antigen level test of Infectious disease (AIDS) and related syndrome evaluation.

Tag

mFc

Products description

Anti-immunodeficiency virus 1/2 (HIV1/2) HIV p24 antigen mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other human immunodeficiency virus 1/2 (HIV p24 antigen) antibodies.

Reconized/Reactive Species

immunodeficiency virus 1/2 (HIV1/2)

Purity

Purity: ≥95% (SDS-PAGE)

Application

ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT

Formulation

Supplied as a 0.2 μM filtered solution of PBS,PH7.4.

Storage

Store at? -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Diagnostic antibodies and antigens for cancer detection - TG, CA-125, SCC Ag, PIVKA-Ⅱ, ProGRP, Calcitonin, NSE, CA-724, HE4, CA15-3, FER, CYFRA21-1, HER2, HSP90α, S100B, CEA, AFP, sFlt-1, PSA, hEGF, TFF2, TFF3, CA199, CA50, TK1

Regardless of the advances in the cancer therapy, delayed symptoms and lack of successful diagnosis of cancer at early stage increased the death rate. Tumor-associated antigens (TAAs) and their antibodies have been identified as potential markers in cancer diagnosis and determination. TAAs and their antibodies-based detection of cancer have the advantages such as low-cost, and simple access, which attracted much attention for early cancer detection. For several reasons, tumor marker itself is typically insufficient to analyze disease conditions. Because, maximum number of markers have been produced by both normal and cancer cells. Several cancers such as anal, breast, ovaries, testicles, colon, endometrial, peritoneal, fallopian tube, gallbladder, gastric, liver, lung, neuroendocrine, pancreatic, prostate, renal, cervix, stomach and thyroid cancer, bronchopulmonary dysplasia, hepatitis, hematological malignancies, hemochromatosis, hypercalcemia, osteoporosis, Parget’s diseases and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.